ArticleDrug design, development and therapy2025

Dasatinib Dose Optimization Based on Therapeutic Drug Monitoring in Patients with Chronic-Phase Chronic Myeloid Leukemia.

Fang Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.